Wellington Global Health Care Equity Fund USD N AcRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 21.1 | 3.4 | 0.2 | -0.2 | 4.8 | |
+/-Cat | 3.6 | -6.0 | 4.8 | 2.9 | 1.0 | |
+/-B’mrk | - | -14.8 | -5.6 | 2.3 | -2.6 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 21/11/2024 | USD 35.92 | |
Day Change | 0.52% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00B84TGD38 | |
Fund Size (Mil) 21/11/2024 | USD 2146.49 | |
Share Class Size (Mil) 21/11/2024 | USD 131.35 | |
Max Initial Charge | - | |
Ongoing Charge 14/03/2024 | 1.33% |
Investment Objective: Wellington Global Health Care Equity Fund USD N Ac |
The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Rebecca Sykes 30/06/2022 | ||
Inception Date 10/01/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Wellington Global Health Care Equity Fund USD N Ac | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.90 |
UnitedHealth Group Inc | Healthcare | 7.18 |
Novo Nordisk A/S | 5.18 | |
AstraZeneca PLC | Healthcare | 4.53 |
Merck & Co Inc | Healthcare | 4.44 |
Increase Decrease New since last portfolio | ||
Wellington Global Health Care Equity Fund USD N Ac |